Trial Profile
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Dose Ranging Study of Erdosteine for the Treatment of Stable Chronic Bronchitis Associated With Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2014
Price :
$35
*
At a glance
- Drugs Erdosteine (Primary)
- Indications Chronic bronchitis; Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Adams Respiratory Therapeutics
- 14 Apr 2014 New trial record